Redsense Medical is selling for under 6.30 as of the 24th of November 2024; that is 0.32 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 6.3. Redsense Medical has about a 22 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Redsense Medical AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of October 2024 and ending today, the 24th of November 2024. Click here to learn more.
Redsense Medical AB provides blood loss detection devices primarily in Europe and the United States. Redsense Medical AB was founded in 2000 and is headquartered in Halmstad, Sweden. Redsense Medical is traded on Stockholm Stock Exchange in Sweden. More on Redsense Medical AB
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Redsense Medical's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Redsense Medical or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Redsense Medical AB (REDS) is traded on Stockholm Exchange in Sweden and employs 5 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 123.97 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Redsense Medical's market, we take the total number of its shares issued and multiply it by Redsense Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Redsense Medical operates under Healthcare sector and is part of Medical Instruments & Supplies industry.
Redsense Medical AB has accumulated about 3.12 M in cash with (7.09 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.28.
Check Redsense Medical Probability Of Bankruptcy
Redsense Medical Risk Profiles
Although Redsense Medical's alpha and beta are two of the key measurements used to evaluate Redsense Medical's performance over the market, the standard measures of volatility play an important role as well.
Our tools can tell you how much better you can do entering a position in Redsense Medical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Commodity Channel Now
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
When running Redsense Medical's price analysis, check to measure Redsense Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Redsense Medical is operating at the current time. Most of Redsense Medical's value examination focuses on studying past and present price action to predict the probability of Redsense Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Redsense Medical's price. Additionally, you may evaluate how the addition of Redsense Medical to your portfolios can decrease your overall portfolio volatility.